Eli Lilly rolls the dice, axing psoriasis prospect and pivoting to follow-up 1 year after $2.4B buyout
Eli Lilly rolls the dice, axing psoriasis prospect and pivoting to follow-up 1 year after $2.4B buyout
ntaylor
СМИ24.net — правдивые новости, непрерывно 24/7 на русском языке с ежеминутным обновлением *